Page last updated: 2024-09-03

bay x 1005 and leukotriene e4

bay x 1005 has been researched along with leukotriene e4 in 3 studies

Compound Research Comparison

Studies
(bay x 1005)
Trials
(bay x 1005)
Recent Studies (post-2010)
(bay x 1005)
Studies
(leukotriene e4)
Trials
(leukotriene e4)
Recent Studies (post-2010) (leukotriene e4)
5868986118122

Protein Interaction Comparison

ProteinTaxonomybay x 1005 (IC50)leukotriene e4 (IC50)
Canalicular multispecific organic anion transporter 1Rattus norvegicus (Norway rat)9.83

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brink, C; Gardiner, PJ; Gascard, JP; Gorenne, I; Labat, C; Mohrs, KH; Müller-Peddinghaus, R; Norel, X; Taylor, WA1
Dahlén, B; Dahlén, SE; Ihre, E; Kumlin, M; Zetterström, O1
Adalsteinsdottir, AE; Agnarsson, U; Andersen, K; Andresdottir, M; Arnar, DO; Bjornsdottir, H; Einarsson, A; Gottskalksson, G; Gudbjartsson, D; Gudmundsdottir, H; Gudmundsson, K; Gulcher, J; Gurney, M; Hakonarson, H; Hardarson, T; Helgadottir, A; Jonsson, A; Kong, A; Kristinsson, A; Kristjansson, K; Manolescu, A; Sigurdsson, A; Stefansson, K; Thorgeirsson, G; Thorvaldsson, S; Topol, EJ; Zink, F1

Trials

2 trial(s) available for bay x 1005 and leukotriene e4

ArticleYear
Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005.
    Thorax, 1997, Volume: 52, Issue:4

    Topics: Adult; Area Under Curve; Asthma; Bronchial Provocation Tests; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans; Leukotriene E4; Lipoxygenase Inhibitors; Male; Middle Aged; Quinolines

1997
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
    JAMA, 2005, May-11, Volume: 293, Issue:18

    Topics: 5-Lipoxygenase-Activating Proteins; Aged; Biomarkers; Carrier Proteins; Coronary Artery Disease; Cross-Over Studies; Epoxide Hydrolases; Female; Humans; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Peroxidase; Polymorphism, Single Nucleotide; Prospective Studies; Quinolines; Risk Factors

2005

Other Studies

1 other study(ies) available for bay x 1005 and leukotriene e4

ArticleYear
(R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl] acetic acid (BAY x1005), a potent leukotriene synthesis inhibitor: effects on anti-IgE challenge in human airways.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:2

    Topics: Bronchi; Bronchoconstriction; Female; Humans; Immunoglobulin E; In Vitro Techniques; Indoles; Indomethacin; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Quinolines

1994